NeuroBo Pharmaceuticals News

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Woodworth Marshall H

Mar 4 21:21 ET

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Tursi James Patrick

Dec 4, 2023 17:12 ET

NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Tursi James Patrick

Nov 2, 2023 16:39 ET

NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Woodworth Marshall H

Oct 30, 2023 16:31 ET

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kim Hyung Heon

Aug 14, 2023 16:10 ET

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KOVEN ANDREW I

Jul 28, 2023 06:19 ET

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Salsbury Michael

Jul 28, 2023 06:17 ET

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director STRICKLAND D GORDON

Jul 28, 2023 06:15 ET

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GROVES JASON L

Jul 28, 2023 06:13 ET

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Glickman Mark A

Jul 28, 2023 06:11 ET

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kim Na Yeon

Jul 28, 2023 06:08 ET

NeuroBo Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Kim Na Yeon

Jul 28, 2023 06:02 ET

NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Glickman Mark A

May 12, 2023 09:44 ET

NeuroBo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Strategic Risk, LLC.(6.3%)

Mar 28, 2023 15:30 ET

NeuroBo Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Altium Growth Fund, LP(0%),Altium Capital Management, LP(0%), etc.

Feb 14, 2023 12:35 ET

NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Hooker Joseph

Jan 18, 2023 16:15 ET

NeuroBo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dong-A ST Co., Ltd.(65.5%)

Dec 29, 2022 19:43 ET

NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner GOLDMAN SACHS GROUP INC

Nov 22, 2022 16:46 ET

NeuroBo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(7.7%),Altium Growth Fund, LP EIN:(7.7%), etc.

Nov 17, 2022 17:08 ET

NeuroBo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dong-A ST Co., Ltd.(2.4%)

Nov 10, 2022 16:14 ET